/co-chair-and-vice-chair-of-igwg-at-fourth-meeting.tmb-1200v.jpg?sfvrsn=77fee812_6)
Global Collaboration Advances Landmark Pandemic Preparedness System
Geneva – In a significant step towards bolstering global health security, representatives from World Health Organization (WHO) Member States concluded a recent round of negotiations focused on establishing the world’s first Pathogen Access and Benefit-Sharing (PABS) system. The intensive discussions, held from December 1st to 5th, 2025, underscore a collective commitment to proactively address future pandemic threats and ensure a more equitable response when they arise. Negotiations will resume in January 2026, demonstrating the urgency and shared responsibility felt by nations worldwide.
The negotiations took place during the fourth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement. Member States agreed to extend the current negotiation phase, scheduling a resumption of talks from January 20th to 22nd, 2026. This PABS system, a key component of the broader WHO Pandemic Agreement, aims to create a globally accessible platform for sharing pathogens and their genetic information, alongside a fair and transparent distribution of benefits derived from their use.
The Pathogen Access and Benefit-Sharing System: A Deep Dive
The establishment of a robust PABS system represents a paradigm shift in global pandemic preparedness. Historically, access to pathogens and the resulting scientific advancements have been unevenly distributed, often favoring wealthier nations and private entities. This inequity can hinder rapid response efforts and exacerbate the impact of outbreaks in vulnerable regions. The PABS system seeks to rectify this imbalance by fostering a collaborative environment where scientific resources are shared openly and equitably.
The core principle behind the PABS system is that access to biological materials crucial for pandemic prevention and response should not be limited by geographical location or economic status. By creating a centralized platform for sharing pathogens and genetic data, the system aims to accelerate research and development of vaccines, diagnostics, and therapeutics. Equally important is the benefit-sharing component, which ensures that countries and communities contributing to the system receive appropriate recognition and tangible benefits, such as technology transfer, capacity building, and financial incentives.
This initiative builds upon lessons learned from recent pandemics, including COVID-19, where delays in sharing data and resources significantly hampered the global response. A key challenge lies in balancing the need for open access with the protection of intellectual property rights and the prevention of misuse of biological materials. The IGWG is actively working to address these concerns through the development of clear governance structures and ethical guidelines.
Did You Know?:
The success of the PABS system hinges on the active participation and cooperation of all WHO Member States, as well as key stakeholders from the private sector, academia, and research institutions. Informal dialogues with these groups, organized by the IGWG Bureau prior to the fourth session, have been instrumental in gathering diverse perspectives and identifying potential areas of consensus. These dialogues will continue in the coming weeks, paving the way for a productive resumed session in January.
But what safeguards will be in place to prevent the misuse of shared pathogens? And how will the system ensure that benefits are distributed fairly, particularly to low- and middle-income countries?
External Link: Global Health Organization – Pandemic Preparedness
External Link: Chatham House – Global Health Security
Statements from Key Leaders
Mr. Matthew Harpur, co-chair of the IGWG Bureau from the United Kingdom, expressed optimism about the progress made, stating, “As we cross the halfway mark in negotiations on the Pathogen Access and Benefit-Sharing (PABS) system, I am encouraged by the progress we’ve made towards enabling a faster and more equitable global response to future pandemics. Member States have demonstrated real commitment to finding common ground and bridging differences, as we work to deliver a strong PABS system by the next World Health Assembly.”
Ambassador Tovar da Silva Nunes, also a co-chair of the IGWG Bureau representing Brazil, added, “WHO Member States have shown their dedication to finishing this important task. The progress achieved on access, benefit-sharing and core governance areas provides the foundation to move the process forward. We are confident we can build a strong and balanced PABS system that will benefit all people.”
WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the significance of this undertaking, declaring, “This is both a generational opportunity and a generational responsibility. I thank Member States and the IGWG Bureau for rising to the occasion. As we get ready to close out this year, we are in a strong position to forge consensus, finalize the draft, and prepare for adoption at next year’s World Health Assembly. Together, we are moving toward a world that is better prepared for future pandemics.”
Frequently Asked Questions About the PABS System
-
What is the primary goal of the Pathogen Access and Benefit-Sharing (PABS) system?
The primary goal is to establish a global system for the timely, fair, and transparent sharing of pathogens and their genetic information, along with the benefits arising from their use, to improve pandemic preparedness and response.
-
How will the PABS system ensure equitable access to benefits for all Member States?
The system aims to ensure equitable access through mechanisms such as technology transfer, capacity building, and financial incentives, particularly for low- and middle-income countries.
-
What role does the Intergovernmental Working Group (IGWG) play in developing the PABS system?
The IGWG is responsible for drafting and negotiating the PABS annex to the WHO Pandemic Agreement, establishing governance structures, and addressing key challenges related to access and benefit-sharing.
-
When is the anticipated completion and adoption of the PABS system?
The draft is expected to be finalized and prepared for adoption at the next World Health Assembly, with negotiations resuming in January and February 2026.
-
What types of stakeholders are involved in the development of the PABS system?
Stakeholders include WHO Member States, representatives from the private sector, academia, laboratories, and sequence information databases.
-
How does the PABS system address concerns about intellectual property rights?
The IGWG is actively working to balance the need for open access with the protection of intellectual property rights through the development of clear governance structures and ethical guidelines.
The ongoing negotiations represent a critical juncture in global health governance. The successful implementation of the PABS system will not only enhance our collective ability to prevent and respond to future pandemics but also foster a more equitable and collaborative approach to global health security. Will this system truly deliver on its promise of a more prepared and equitable world, or will political and economic hurdles prove insurmountable?
Share this article to help raise awareness about this vital initiative! Join the conversation in the comments below.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or legal advice.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
